by Maria Zannes | Oct 15, 2015 | Events, Press Releases
OCTOBER 15, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies, a privately held cancer diagnostics company, presented its breakthrough technology for the detection and diagnosis of early-stage lung cancer today at McDermott Will & Emery’s 2015...
by Maria Zannes | Oct 12, 2015 | News
OCTOBER 12, 2015 As published in the San Antonio Business Journal By W. Scott Bailey bioAffinity Technologies Inc., a development-stage biotech company launched in San Antonio in March 2014, has found solid footing in South Texas. It’s also found interest from East...
by Maria Zannes | Oct 7, 2015 | Press Releases
OCTOBER 7, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies, a privately held cancer diagnostics company, will seat two new members on its Board of Directors at the third-quarter meeting Oct. 26, 2015. Company President and Chief Executive Officer Maria Zannes...
by Maria Zannes | Oct 4, 2015 | News
OCTOBER 4, 2015 By Maria Zannes, President & Chief Executive Officer (SAN ANTONIO, TX ) Early detection of cancer prolongs life. Each of us at bioAffinity Technologies has seen this firsthand. Our brothers, sisters, parents, friends and patients, and many of us...
by Maria Zannes | Sep 30, 2015 | Press Releases
SEPTEMBER 30, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies, a privately held cancer diagnostics company, today announced the renewal of its research collaboration with The University of Texas Health Science Center at San Antonio to optimize its patented CyPath®...
